Company intelligence
Department of Biomedicine
We unite basic & clinical scientists to advance our understanding of health & disease & to develop pioneering therapies.
About Department of Biomedicine
The Department of Biomedicine is a joint venture of the University of Basel and the University Hospitals Basel. It unites basic and clinical scientists to advance our understanding of health and disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. The Department fosters curiosity-driven and interdisciplinary science, providing a stimulating environment to train the next generation of scientific leaders in all areas of biomedicine. With state-of-the-art facilities and a cutting-edge research environment, it nurtures a spirit of innovation. The Department is strategically situated in the heart of Basel in close vicinity to the university hospitals, to other academic and industrial biomedical institutions, contributing to one of Europe’s top life science hubs.
Verified activity
Signals from Department of Biomedicine
8 published signals
Research & Knowledge
Department of Biomedicine researchers led by Gonçalo Bernardes and Gregor Hutter published a study in Cancer Research published in the AACR journals.
Reported by Department of Biomedicine
Research & Knowledge
Department of Biomedicine researchers from the University of Basel and the University of Cambridge developed small molecules called Phagocytic Synapse Enhancers (PSEs) to reprogram macrophages to engulf cancer cells and weaken the immunosuppressive tumor microenvironment.
Reported by Department of Biomedicine
Presence & Recognition
Department of Biomedicine announced that Computational Hematology Training (CBTH) is running before applications close on 15 September.
Reported by Judith Zaugg
Research & Knowledge
Department of Biomedicine received TANDEM grants from the ISREC Foundation to support two research projects addressing how cancer cells evade the immune system and how to counteract these mechanisms.
Reported by Department of Biomedicine
Research & Knowledge
Department of Biomedicine researchers Petya Apostolova and Karen Dixon received two ERC Starting Grants to pursue research projects at the Department of Biomedicine.
Reported by Department of Biomedicine
Research & Knowledge
Department of Biomedicine researchers screened over 1,600 compounds to identify promising drugs and develop combinations designed to work across biologically different tumors.
Reported by Department of Biomedicine
Research & Knowledge
Department of Biomedicine researchers developed a three-drug combination that slowed tumor growth more effectively than regorafenib alone in an animal model.
Reported by Department of Biomedicine
Research & Knowledge
Department of Biomedicine established a collection of patient-derived liver cancer organoids led by MarkusHeim and Sandro Nuciforo to capture tumor diversity across patients.
Reported by Department of Biomedicine